Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Saada

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
RNA (New York, N.Y.)|June 26, 2014
eIF4F-like complexes formed by cap-binding homolog TbEIF4E5 with TbEIF4G1 or TbEIF4G2 are implicated in post-transcriptional regulation in Trypanosoma bruceiEden R Freire, Ajay A Vashisht, Amaranta M Malvezzi, et al.
Scientific Reports|April 27, 2023
Lipid-coated mesoporous silica nanoparticles for anti-viral applications via delivery of CRISPR-Cas9 ribonucleoproteinsAnnette E LaBauve, Edwin A Saada, Iris K A Jones, et al.
Acta Biomaterialia|July 24, 2020
Engineering of monosized lipid-coated mesoporous silica nanoparticles for CRISPR deliveryAchraf Noureddine, Angelea Maestas-Olguin, Edwin A Saada, et al.
Mabs|August 4, 2021
Development of potent and effective synthetic SARS-CoV-2 neutralizing nanobodiesMaxwell A Stefan, Yooli K Light, Jennifer L Schwedler, et al.
Clinical Genetics|August 31, 2016
Mitochondrial epileptic encephalopathy, 3-methylglutaconic aciduria and variable complex V deficiency associated with TIMM50 mutationsM A Shahrour, O Staretz-Chacham, D Dayan, et al.
Frontiers in Molecular Biosciences|July 30, 2021
Discovery of Small-Molecule Inhibitors of SARS-CoV-2 Proteins Using a Computational and Experimental PipelineEdmond Y Lau, Oscar A Negrete, W F Drew Bennett, et al.
Biorxiv : the Preprint Server for Biology|November 3, 2022
Computationally restoring the potency of a clinical antibody against SARS-CoV-2 Omicron subvariantsThomas A Desautels, Kathryn T Arrildt, Adam T Zemla, et al.
Nature|May 8, 2024
Computationally restoring the potency of a clinical antibody against OmicronThomas A Desautels, Kathryn T Arrildt, Adam T Zemla, et al.
Scientific Data|November 19, 2025
14,441 Genomics-Based Validated Automated Comprehensive Clinicopathologic Correlations for Myeloid NeoplasmsAhmed Elsafty, Yomna Ahmed, Taher F Halawa, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
RNA (New York, N.Y.)|June 26, 2014
eIF4F-like complexes formed by cap-binding homolog TbEIF4E5 with TbEIF4G1 or TbEIF4G2 are implicated in post-transcriptional regulation in Trypanosoma bruceiEden R Freire, Ajay A Vashisht, Amaranta M Malvezzi, et al.
Scientific Reports|April 27, 2023
Lipid-coated mesoporous silica nanoparticles for anti-viral applications via delivery of CRISPR-Cas9 ribonucleoproteinsAnnette E LaBauve, Edwin A Saada, Iris K A Jones, et al.
Acta Biomaterialia|July 24, 2020
Engineering of monosized lipid-coated mesoporous silica nanoparticles for CRISPR deliveryAchraf Noureddine, Angelea Maestas-Olguin, Edwin A Saada, et al.
Mabs|August 4, 2021
Development of potent and effective synthetic SARS-CoV-2 neutralizing nanobodiesMaxwell A Stefan, Yooli K Light, Jennifer L Schwedler, et al.
Clinical Genetics|August 31, 2016
Mitochondrial epileptic encephalopathy, 3-methylglutaconic aciduria and variable complex V deficiency associated with TIMM50 mutationsM A Shahrour, O Staretz-Chacham, D Dayan, et al.
Frontiers in Molecular Biosciences|July 30, 2021
Discovery of Small-Molecule Inhibitors of SARS-CoV-2 Proteins Using a Computational and Experimental PipelineEdmond Y Lau, Oscar A Negrete, W F Drew Bennett, et al.
Biorxiv : the Preprint Server for Biology|November 3, 2022
Computationally restoring the potency of a clinical antibody against SARS-CoV-2 Omicron subvariantsThomas A Desautels, Kathryn T Arrildt, Adam T Zemla, et al.
Nature|May 8, 2024
Computationally restoring the potency of a clinical antibody against OmicronThomas A Desautels, Kathryn T Arrildt, Adam T Zemla, et al.
Scientific Data|November 19, 2025
14,441 Genomics-Based Validated Automated Comprehensive Clinicopathologic Correlations for Myeloid NeoplasmsAhmed Elsafty, Yomna Ahmed, Taher F Halawa, et al.
Pageof 6